Breaking News Instant updates and real-time market news.

2018-10-12 07:15:24 LXP Lexington Realty $7.80 -0.23 (-2.86%) 07:15 10/12/18 10/12 07:15 10/12/18 07:15	Lexington Realty upgraded to Buy from Hold at Jefferies Jefferies analyst Jonathan Petersen upgraded Lexington Realty Trust to Buy and raised his price target for the shares to $10 from $9. While the pending dividend cut has driven yield investors "to the exits," Lexington's shift toward industrial properties and away from office can drive greater than 50% multiple expansion, Petersen tells investors in a research note. He believes this can offset the 30% earnings dilution from the shift.
LXP Lexington Realty $7.80 -0.23 (-2.86%) 09/27/18 WELS 09/27/18 UPGRADE Target $9 WELS Outperform Lexington Realty upgraded to Outperform from Market Perform at Wells Fargo Wells Fargo analyst Todd Stender upgraded Lexington Realty Trust to Outperform and raised his price target for the shares to $9 from $8.50. The analyst likes company's recent announcement to sell a meaningful single-tenant suburban office building portfolio into a joint venture with Davidson Kempner Capital Management. He views Lexington's strategic shift favorably though does acknowledge the earnings dilution and potential dividend cut that may result. Now the company can focus on building out a more competitive footprint within one of the most sought-after property types within the overall REIT group, Industrial/Distribution, which should lead to multiple expansion, Stender tells investors in a research note. 08/08/18 08/08/18 NO CHANGE Lexington Realty backs FY18 adjusted FFO view 95c-98c, consensus 97c 05/09/18 05/09/18 DOWNGRADE Target $7 Sell Lexington Realty downgraded to Sell on view of 'painful transition' at Stifel As previously reported, Stifel analyst John Guinee downgraded Lexington Realty to Sell from Hold as he sees little chance of FFO growth, does not like the real estate valuation metrics and projects a "painful transition" will be required. Guinee also cites a lack of confidence in the current dividend. He lowered his price target on Lexington Realty to $7.00 from $8.50. 05/08/18 STFL 05/08/18 DOWNGRADE STFL Sell Lexington Realty downgraded to Sell from Hold at Stifel

2018-10-12 07:15:24

LXP

Lexington Realty

$7.80: -0.23 (-2.86%)

07:15

10/12/18

10/12

07:15

10/12/18

07:15

Lexington Realty upgraded to Buy from Hold at Jefferies

Jefferies analyst Jonathan Petersen upgraded Lexington Realty Trust to Buy and raised his price target for the shares to $10 from $9. While the pending dividend cut has driven yield investors "to the exits," Lexington's shift toward industrial properties and away from office can drive greater than 50% multiple expansion, Petersen tells investors in a research note. He believes this can offset the 30% earnings dilution from the shift.

LXP Lexington Realty

$7.80: -0.23 (-2.86%)

09/27/18: WELS

08/08/18

05/09/18

05/08/18: STFL

TODAY'S FREE FLY STORIES

UAA Under Armour $21.26 -0.02 (-0.09%) , UA Under Armour $19.22 0.025 (0.13%) 10:52 02/21/19 02/21 10:52 02/21/19 10:52 Periodicals	Under Armour CEO questioned by board about ties with MSNBC anchor, WSJ says » A number of current and… UAA Under Armour $21.26 -0.02 (-0.09%) UA Under Armour $19.22 0.025 (0.13%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	03 Mar 06 Mar
10:50 02/21/19 02/21 10:50 02/21/19 10:50 General news	U.S. corporate bond update: issuance continues apace today » U.S. corporate bond… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial
COUP Coupa Software $92.39 -1.36 (-1.45%) 10:50 02/21/19 02/21 10:50 02/21/19 10:50 Options	Short-term hedge opened in Coupa Software » Short-term hedge opened… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	11 Mar 11 Mar 12 Mar 12 Mar
10:50 02/21/19 02/21 10:50 02/21/19 10:50 General news	FX Action: USD-JPY » FX Action: USD-JPY has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
OHRP Ohr Pharmaceutical $2.01 (0.00%) 10:47 02/21/19 02/21 10:47 02/21/19 10:47 Hot Stocks	Ohr Pharmaceutical regains compliance with Nasdaq listing requirements » Ohr Pharmaceutical… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

IMDZ Immune Design $5.81 4.385 (307.72%) , MRK Merck $79.79 0.35 (0.44%) 10:46 02/21/19 02/21 10:46 02/21/19 10:46 Downgrade	Immune Design, Merck rating change » Immune Design downgraded… IMDZ Immune Design $5.81 4.385 (307.72%) MRK Merck $79.79 0.35 (0.44%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	05 Mar 11 Apr 18 May 17 Jun
10:45 02/21/19 02/21 10:45 02/21/19 10:45 General news	Breaking General news story » 3-Month Bill Announcement… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
10:45 02/21/19 02/21 10:45 02/21/19 10:45 General news	Breaking General news story » 6-Month Bill Announcement… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial
ANET Arista Networks $266.95 -3.58 (-1.32%) 10:45 02/21/19 02/21 10:45 02/21/19 10:45 Conference/Events	Arista Networks has a conference call hosted by JPMorgan » JPMorgan Analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	21 Feb 25 Feb 25 Feb 25 Feb 25 Feb 26 Feb 27 Feb 28 Feb 04 Mar 12 Mar 13 Mar 13 Mar
10:45 02/21/19 02/21 10:45 02/21/19 10:45 General news	Breaking General news story » Week of 2/15 EIA… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial

NKE Nike $83.97 -0.87 (-1.03%) 10:40 02/21/19 02/21 10:40 02/21/19 10:40 On The Fly	Analyst sees 'minimal' lasting damage to Nike brand after Duke star's shoe splits » Shares of Nike (NKE)… Open Full Text 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
WFT Weatherford $0.79 -0.0263 (-3.21%) 10:40 02/21/19 02/21 10:40 02/21/19 10:40 Options	10.1K Weatherford Mar 1 calls trade as shares drop 2c to 80c » 10.1K Weatherford Mar 1… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	22 May
10:40 02/21/19 02/21 10:40 02/21/19 10:40 General news	Treasury Action: yields have cheapened despite some disappointing data » Treasury Action: yields… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial
KAR KAR Auction $48.30 1.56 (3.34%) 10:37 02/21/19 02/21 10:37 02/21/19 10:37 Upgrade	KAR Auction rating change » KAR Auction upgraded to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	27 Feb 07 Mar 13 Mar 14 Mar
NCLH Norwegian Cruise Line $55.71 1.99 (3.70%) 10:32 02/21/19 02/21 10:32 02/21/19 10:32 Recommendations	Norwegian Cruise Line analyst commentary » Buckingham says backdrop… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	21 Feb 03 Mar 28 May

BSX Boston Scientific $40.03 -0.1 (-0.25%) 10:30 02/21/19 02/21 10:30 02/21/19 10:30 Options	Bullish option flow in Boston Scientific » Bullish option flow in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	27 Feb 27 Feb 06 Mar 18 May 28 May
SNPS Synopsys $100.68 -2.3 (-2.23%) 10:26 02/21/19 02/21 10:26 02/21/19 10:26 Recommendations	Synopsys analyst commentary » Synopsys weakness a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	25 Feb 25 Feb 25 Feb 26 Feb 26 Feb 03 Mar 08 Mar 14 Mar 17 Mar 16 Jul 17 Jul 26 Sep 27 Sep
NWL Newell Brands $17.18 0.05 (0.29%) 10:25 02/21/19 02/21 10:25 02/21/19 10:25 Periodicals	Newell Brands CEO faces board pressure following poor sales, WSJ reports » Newell Brands CEO Michael… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	21 Feb
10:25 02/21/19 02/21 10:25 02/21/19 10:25 Conference/Events	Morgan Stanley consumer goods analysts to hold analyst/industry conference call » Executive Director of… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial
BIIB Biogen $323.78 -11.23 (-3.35%) , ESALY Eisai $0.00 (0.00%) 10:25 02/21/19 02/21 10:25 02/21/19 10:25 Conference/Events	JPMorgan large-cap biotech analysts to hold an analyst/industry conference call » Large Cap Biotech Analyst… BIIB Biogen $323.78 -11.23 (-3.35%) ESALY Eisai $0.00 (0.00%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	21 Feb 25 Feb 28 May

10:25 02/21/19 02/21 10:25 02/21/19 10:25 Conference/Events	JPMorgan retail analysts to hold an analyst/industry conference call » Retail Analysts Boss and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial
10:25 02/21/19 02/21 10:25 02/21/19 10:25 Conference/Events	Morgan Stanley sports/footwear analyst to hold analyst/industry conference call » Sports & Footwear… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial
EEM iShares MSCI Emerging Markets ETF $42.48 -0.175 (-0.41%) 10:20 02/21/19 02/21 10:20 02/21/19 10:20 Options	Size three-way spread in iShares Emerging Markets Fund as shares tick lower » Size three-way spread in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
$NSD NASDAQ Market Internals $0.00 (0.00%) 10:17 02/21/19 02/21 10:17 02/21/19 10:17 Technical Analysis	NASDAQ market internals summary » Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
$NYE NYSE Market Internals $0.00 (0.00%) 10:16 02/21/19 02/21 10:16 02/21/19 10:16 Technical Analysis	NYSE market internals summary » Volume is average for… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

Events

Earnings calls, analyst events, roadshows and more

Today at 11:00

2-Year Note Announcement Government Event
Today at 11:00

5-Year Note Announcement Government Event
Today at 11:00

3-Month Bill Announcement Government Event
Today at 11:00

6-Month Bill Announcement Government Event
Today at 11:00

52-Week Bill Announcement Government Event
MCS
Today at 11:00

Marcus - MCS Conference Calls
FLS
Today at 11:00

Flowserve - FLS Conference Calls
MUX
Today at 11:00

McEwen Mining - MUX Conference Calls
OGS
Today at 11:00

One Gas - OGS Conference Calls
CPRT
Today at 11:00

Copart - CPRT Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	AI X AI Arlington Asset Investment Spot Secondary Managers: Morgan Stanley & JMP Securities Priced at: $8.33 6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ARR X ARR ARMOUR Residential Spot Secondary Managers: Morgan Stanley & Barclays, Citi, Credit Suisse, Goldman Sachs & JPMorgan Priced at: $20.33 7.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CPT X CPT Camden Property Spot Secondary Managers: BofA/Merrill & Deutsche Bank Priced at: $97.85 3.375M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NRZ X NRZ New Residential Spot Secondary Managers: Morgan Stanley, Credit Suisse & JPMorgan Priced at: $16.50 40.3M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial OVID X OVID Ovid Therapeutics Spot Secondary Managers: Cowen & William Blair Priced at: $2.00 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SNNA X SNNA Sienna Biopharmaceuticals Spot Secondary Managers: Cowen & BMO Capital Priced at: $2.50 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	RWLK X RWLK ReWalk Robotics Spot Secondary Managers: H.C. Wainwright Priced at: $.23 19M Shares
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Lexington Realty upgraded to Buy from Hold at Jefferies

TODAY'S FREE FLY STORIES

Get Full Fly Access